Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harte Hanks (HHS) Invested Capital (2016 - 2025)

Harte Hanks (HHS) has disclosed Invested Capital for 16 consecutive years, with $19.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 7.54% to $19.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.9 million, a 7.54% decrease, with the full-year FY2024 number at $22.5 million, up 13.17% from a year prior.
  • Invested Capital was $19.9 million for Q3 2025 at Harte Hanks, down from $22.9 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $22.9 million in Q2 2025 to a low of -$53.9 million in Q1 2021.
  • A 5-year average of $3.7 million and a median of $19.9 million in 2025 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: fell 21.7% in 2021, then surged 260.33% in 2023.
  • Harte Hanks' Invested Capital stood at -$19.7 million in 2021, then soared by 195.4% to $18.8 million in 2022, then rose by 5.58% to $19.9 million in 2023, then grew by 13.17% to $22.5 million in 2024, then decreased by 11.53% to $19.9 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Invested Capital are $19.9 million (Q3 2025), $22.9 million (Q2 2025), and $21.4 million (Q1 2025).